Search

Your search keyword '"Balog, Attila"' showing total 232 results

Search Constraints

Start Over You searched for: Author "Balog, Attila" Remove constraint Author: "Balog, Attila"
232 results on '"Balog, Attila"'

Search Results

2. Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study

3. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis

5. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis

6. Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study

7. Comparative single-cell multiplex immunophenotyping of therapy-naive patients with rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus shed light on disease-specific composition of the peripheral immune system.

10. Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2

18. Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2

27. Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study

29. A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

30. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients

36. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

37. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

38. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases.

39. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

41. Kynurenic Acid Analog Attenuates the Production of Tumor Necrosis Factor-α, Calgranulins (S100A 8/9 and S100A 12), and the Secretion of HNP1–3 and Stimulates the Production of Tumor Necrosis Factor-Stimulated Gene-6 in Whole Blood Cultures of Patients With Rheumatoid Arthritis

42. TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis

43. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases

44. COVID-19: a citokinviharon innen és túl

45. Standardization procedure for flow cytometry data harmonization in prospective multicenter studies

48. O31 Integrative analysis reveals a molecular stratification of systemic autoimmune diseases

49. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

Catalog

Books, media, physical & digital resources